Related Experiment Video
Updated: Sep 11, 2025

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma
Johanna Mangana1, Berna C Özdemir2, Daniela Mihic-Probst3
1Skin Cancer Centre, Department of Dermatology, University of Zurich, University Hospital of Zurich, Zurich, Switzerland.
Abstract:
Despite the globally rising incidence of melanoma, mortality rates have decreased by approximately 18% in Caucasian populations following the introduction of effective systemic treatments. Thanks to new molecular insights, the management of cutaneous melanoma has undergone several transformations over the past decade. The existing guidelines were last updated in 2016 to provide evidence-based practical recommendations for melanoma specialists across Switzerland. Recent data on surgical, radiotherapeutic and mainly systemic treatment with the implementation of adjuvant and neoadjuvant treatments in the current melanoma management have made modifications of the treatment and follow-up recommendations necessary.
Insights
Melanoma treatment has advanced significantly due to new molecular discoveries, leading to improved outcomes. Updated guidelines are now essential to incorporate recent surgical, radiotherapeutic, and systemic therapies, including adjuvant and neoadjuvant approaches.
Area of Science:
- Oncology
- Dermatology
- Medical Guidelines
Background:
- Global incidence of melanoma is rising.
- Mortality rates in Caucasian populations have decreased by 18% due to effective systemic treatments.
- Melanoma management has transformed over the last decade owing to molecular insights.
Purpose of the Study:
- To update the 2016 Swiss guidelines for melanoma management.
- To incorporate recent advancements in surgical, radiotherapeutic, and systemic treatments.
- To provide evidence-based recommendations for adjuvant and neoadjuvant therapies.
Main Methods:
- Review of recent clinical data on melanoma treatment.
- Analysis of surgical, radiotherapeutic, and systemic therapy outcomes.
- Synthesis of evidence for guideline modification.
Main Results:
- Significant advancements in systemic treatments have improved melanoma survival.
- Adjuvant and neoadjuvant therapies represent key developments in current management.
- The 2016 guidelines require substantial updates to reflect current practices.
Conclusions:
- Updated guidelines are crucial for effective melanoma management.
- Recommendations must integrate novel treatment modalities.
- Modified guidelines will support optimal patient care and follow-up.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy

